- Home
- CYTH vs CKX Comparison
CYTH vs CKX Comparison
Compare CYTH & CKX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTH
- CKX
- Stock Information
- Founded
- CYTH 1990
- CKX 1930
- Country
- CYTH United States
- CKX United States
- Employees
- CYTH N/A
- CKX N/A
- Industry
- CYTH Biotechnology: Pharmaceutical Preparations
- CKX Oil & Gas Production
- Sector
- CYTH Health Care
- CKX Energy
- Exchange
- CYTH Nasdaq
- CKX Nasdaq
- Market Cap
- CYTH 26.2M
- CKX 23.8M
- IPO Year
- CYTH N/A
- CKX 1998
- Fundamental
- Price
- CYTH $0.76
- CKX $11.34
- Analyst Decision
- CYTH Buy
- CKX
- Analyst Count
- CYTH 3
- CKX 0
- Target Price
- CYTH $0.95
- CKX N/A
- AVG Volume (30 Days)
- CYTH 44.3K
- CKX 11.3K
- Earning Date
- CYTH 03-17-2025
- CKX 01-01-0001
- Dividend Yield
- CYTH N/A
- CKX N/A
- EPS Growth
- CYTH N/A
- CKX N/A
- EPS
- CYTH N/A
- CKX 0.22
- Revenue
- CYTH $870,725.00
- CKX $2,030,981.00
- Revenue This Year
- CYTH N/A
- CKX N/A
- Revenue Next Year
- CYTH $24.49
- CKX N/A
- P/E Ratio
- CYTH N/A
- CKX $49.37
- Revenue Growth
- CYTH N/A
- CKX 88.35
- 52 Week Low
- CYTH $0.55
- CKX $10.60
- 52 Week High
- CYTH $1.92
- CKX $14.44
- Technical
- Relative Strength Index (RSI)
- CYTH 54.14
- CKX 36.47
- Support Level
- CYTH $0.70
- CKX $10.60
- Resistance Level
- CYTH $0.87
- CKX $11.94
- Average True Range (ATR)
- CYTH 0.07
- CKX 0.46
- MACD
- CYTH -0.00
- CKX -0.05
- Stochastic Oscillator
- CYTH 49.91
- CKX 38.15
About CYTH Cyclo Therapeutics Inc.
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.
About CKX CKX Lands Inc.
CKX Lands Inc is a Louisiana corporation organized to receive non-producing mineral royalties spun off by a southwest Louisiana bank. It operates in three segments: Oil and Gas, Surface, and Timber. The company owns land and mineral interests and collects income through its ownership in the form of oil and gas royalties, surface leases for farming, the right of way and other uses, and timber sales. The company's oil and gas royalties are paid by the operators who own the wells and timber income is paid by the highest bidder for the timber. CKX has small royalty interests in approximately 20 different producing oil and gas fields.